Back
RBC Quant U.S. Dividend Leaders ETF Vs. Janux Therapeutics Industry Stock Comparison
Buy
69
RUD.TO
RBC Quant U.S. Dividend Leaders ETF
Last Price:
$25.82
Seasonality Move:
1.9%
Sell
23
JANX
Janux Therapeutics
Last Price:
$50.53
Seasonality Move:
80.32%
Buy
69
RBC Quant U.S. Dividend Leaders ETF (RUD.TO)
is a Buy
Is RBC Quant U.S. Dividend Leaders ETF a Buy, Sell or Hold?
-
The current RBC Quant U.S. Dividend Leaders ETF [RUD.TO] share price is $25.68. The Score for RUD.TO is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
-
RUD.TO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
23
Janux Therapeutics (JANX)
is a Sell
Is Janux Therapeutics a Buy, Sell or Hold?
-
The current Janux Therapeutics [JANX] share price is $50.82. The Score for JANX is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
-
JANX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RUD.TO Stock Price Chart
What is RBC Quant U.S. Dividend Leaders ETF's stock price today?
-
The RBC Quant U.S. Dividend Leaders ETF share price today is $25.68The current trend is relatively stagnant and RUD.TO is experiencing buying pressure, which is a positive indicator for future bullish movement.
JANX Stock Price Chart
What is Janux Therapeutics's stock price today?
-
The Janux Therapeutics share price today is $50.82Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and JANX is experiencing selling pressure, which indicates risk of future bearish movement.
RUD.TO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.03 | Buy |
Relative Strength Index (14 RSI): | 50.88 | Buy |
Chaikin Money Flow: | 8398 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (25.59 - 26.01) | Sell |
Bollinger Bands (100): | (23.35 - 25.63) | Buy |
JANX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.52 | Sell |
Relative Strength Index (14 RSI): | 41.88 | Sell |
Chaikin Money Flow: | -1994706 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (53.74 - 62.68) | Sell |
Bollinger Bands (100): | (44.76 - 56.7) | Buy |
RUD.TO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 25.64 | Buy |
20-day SMA: | 25.74 | Sell |
50-day SMA: | 25.48 | Buy |
200-day SMA: | 23.2 | Buy |
8-day EMA: | 25.67 | Buy |
20-day EMA: | 25.68 | Buy |
50-day EMA: | 25.36 | Buy |
200-day EMA: | 23.29 | Buy |
JANX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 53.68 | Sell |
20-day SMA: | 56.78 | Sell |
50-day SMA: | 54.64 | Sell |
200-day SMA: | 47.7 | Buy |
8-day EMA: | 54.12 | Sell |
20-day EMA: | 55.17 | Sell |
50-day EMA: | 54.12 | Sell |
200-day EMA: | 45.19 | Buy |
RBC Quant U.S. Dividend Leaders ETF Earnings Growth & RUD.TO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Janux Therapeutics Earnings Growth & JANX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.92 per share, and a decrease next year of $0.75 per share.
RBC Quant U.S. Dividend Leaders ETF Technical Analysis
Dec 20 | Dec 24 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
20 | 24 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Janux Therapeutics Technical Analysis
Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |